Betoftan eye drops 0.5% 5ml
Condition: New product
1000 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Betaxolol
Composition
Betaxolol (in the form of hydrochloride) 5 mg. Excipients: sodium hydrophosphate dodecahydrate, sodium dihydrophosphate monohydrate, sodium chloride, disodium edetate dihydrate, benzalkonium chloride, purified water.
Pharmacological effect
Antiglaucoma drug. Betaxolol is a selective beta1-blocker without internal sympathomimetic activity. Does not possess membrane stabilizing (local anesthetic) action. When applied topically, betaxolol reduces both elevated and normal intraocular pressure, due to a decrease in the production of intraocular fluid. The onset of the hypotensive effect is usually observed 30 minutes after using the drug, and the maximum decrease in IOP occurs after about 2 hours. After a single instillation, the effect on the IOP persists for 12 hours. Betaxolol does not cause a decrease in blood flow in the optic nerve, miosis, accommodation spasm, hemeralopia (unlike miotics).
Indications
- ocular hypertension - chronic open-angle glaucoma - angle-closure glaucoma (in combination with myotics).
Contraindications
- sinus bradycardia - AV block II and III degrees - SSSU - children and adolescents under 18 years of age (due to the lack of data on efficacy and safety) - hypersensitivity to the drug components. With caution, the drug is prescribed for diabetes mellitus, thyrotoxicosis, simultaneous administration of oral beta-blockers, Raynaud's syndrome, pheochromocytoma, bronchial asthma, chronic obstructive bronchitis, AV-blockade I degree, heart failure.
Use during pregnancy and lactation
The use of the drug during pregnancy and lactation (breastfeeding) is possible only in the case when the intended benefit to the mother outweighs the potential risk to the fetus or child.
Dosage and administration
Instill 1-2 drops in the conjunctival sac 2 times / day. In some patients, stabilization of intraocular pressure occurs within a few weeks, therefore it is recommended to control intraocular pressure during the first month of treatment.If the required level of intraocular pressure is not achieved with monotherapy with Betoftan, additional therapy should be prescribed.
Side effects
Local reactions: short-term discomfort in the eyes after instillation, lacrimation. in some cases - lowering the sensitivity of the cornea, redness of the eye, keratitis, photophobia, anisocoria, blurred vision, itching, feeling of dry eyes, allergic reactions. Systemic side effects are rare. From the side of the central nervous system: dizziness, nausea, drowsiness, insomnia, headache, depression, increased symptoms of myasthenia. Since the cardiovascular system: bradycardia, a violation of cardiac conduction and heart failure. On the part of the respiratory system: dyspnea, bronchospasm, bronchial asthma, respiratory failure.
special instructions
Local reactions: short-term discomfort in the eyes after instillation, lacrimation. in some cases - lowering the sensitivity of the cornea, redness of the eye, keratitis, photophobia, anisocoria, blurred vision, itching, feeling of dry eyes, allergic reactions. Systemic side effects are rare. From the side of the central nervous system: dizziness, nausea, drowsiness, insomnia, headache, depression, increased symptoms of myasthenia. Since the cardiovascular system: bradycardia, a violation of cardiac conduction and heart failure. On the part of the respiratory system: dyspnea, bronchospasm, bronchial asthma, respiratory failure.